Oncotarget The Evolution of Metastatic Cancer: Mechanisms and Drivers The Trending With Impact series highlights Oncotarget publications attracting higher visibility among readers around the... read more April 14, 2023
Oncotarget Targeting Pre-Leukemic Cells: New Hope for Preventing Childhood B-ALL Researchers from Universidad Autónoma de Madrid published a new editorial in Oncotarget detailing a... read more March 31, 2023
Oncotarget Unconventional Protein Secretion (UPS) in Cancer Researchers from The Jikei University School of Medicine published a recent editorial perspective in Oncotarget,... read more March 16, 2023
Oncotarget Controlling Glycolytic Flux: Therapy Challenges and Solutions In a new editorial paper, researchers from the University of Oxford explore challenges and potential... read more February 16, 2023
Oncotarget The Importance of CD56 in the Fight Against Multiple Myeloma In a new Oncotarget editorial, researchers discussed their study on CD56 in multiple myeloma.The... read more February 2, 2023
Oncotarget Researchers Identify New Drug Candidates to Treat DLST+ Tumors The increased expression of DLST has recently been associated with increased tumor aggression and a... read more January 19, 2023
Oncotarget Protein-Based Risk Model Predicts Esophageal Cancer Recurrence Researchers developed a multi-protein expression-based risk model to predict recurrence-free survival for ESCC patients.The... read more September 23, 2022
Oncotarget Does a Mechanism Linking Cellular Aging to Cellular Quiescence Exist? Researchers found that diverse geroprotectors differently affect a mechanism linking cellular aging to cellular quiescence... read more August 5, 2022
Oncotarget How Heartburn Can Turn Into Esophageal Cancer, and a Possible Biomarker In a recent Oncotarget paper, researchers investigated telomere shortening in patients with Barrett's esophagus as... read more July 15, 2022
Oncotarget New Tool Uses NF-κB Activity to Classify HPV+ Head and Neck Cancer Researchers developed a new tool aimed at better classifying HPV+ HNSCC patients with good or... read more May 26, 2022